NMS-013 - Transforming evidence into practice: Bisacodyl's dual approach to constipation treatment

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: NMS-013
• By: GAWA, Epainete
• Co-author(s): Abdulsalam Aliyu (Nottingham NIHR Research Centre and School of Medicine, University of Nottingham, Nottingham, United Kingdom)
  Alexia Aran (Opella Healthcare, a Sanofi company, Barcelona, Spain)
  Beatrice Bois De Fer (Opella Healthcare, a Sanofi company, Neuilly-sur-Seine, France)
  Paula Fontanilla (Opella Healthcare, a Sanofi company, Neuilly-sur-Seine, France)
  Epainete Gawa (Opella Healthcare, a Sanofi company, Neuilly-sur-Seine, France)
  
• Abstract:

  Introduction: Bisacodyl, a stimulant laxative, is widely used for relieving constipation. To elucidate the mode of action of bisacodyl, Magnetic Resonance Imaging was used to define the mechanisms underlying the laxative effect of bisacodyl in two independent studies.
  
  Method: In these two randomised, double-blind, placebo-controlled, cross-over..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login